Considering the absence of leukemia blasts in the peripheral blood and bone marrow in isolated EM‐ALL patients, the questions of whether CAR T cells can successfully expand in these patients and whether these patients can benefit from CD19 CAR T therapy remain unanswered. Here, CD19 is linked to leukemia.